PRECISELY ENGINEERING THE FUTURE OF OPHTHALMOLOGYTM
Cutting Edge Company
At Envisia, a talented team of scientists is harnessing the unique characteristics of a powerful product development engine, to create products that have the potential to transform the treatment of ocular disease.
The PRINT® Technology
Envisia is focused on developing safe and effective therapeutics based on biocompatible polymers that enable the delivery of medicines with extended-release kinetics.
Creating compelling new ophthalmology productsthat have the potential to protect and preserve vision and make patients' lives better.
Transformative New Ophthalmology Company Licenses Technology from Liquidia
RESEARCH TRIANGLE PARK, NC– November 12, 2013 – Envisia Therapeutics, a new biotechnology company formed by Liquidia Technologies,................READ MORE